NAD+ IV Therapy Contraindications: Who Should Avoid It and Why
A physician's guide to NAD+ IV therapy contraindications — cancer history, active infections, G6PD deficiency, cardiac conditions, and pregnancy.
Longevity Medicine
Moderate EvidenceNicotinamide adenine dinucleotide IV infusions and precursors for cellular energy restoration.
A physician's guide to NAD+ IV therapy contraindications — cancer history, active infections, G6PD deficiency, cardiac conditions, and pregnancy.
Dr. Julian Douwes walks through NAD IV therapy from pre-session prep to post-infusion recovery — what sensations are normal, and when to flag concerns.
Pterostilbene offers 4× greater bioavailability than resveratrol with longer half-life. Compare clinical evidence, dosing, and Dr. Douwes's protocol for stilbene supplementation.
How mitochondrial dysfunction drives fatigue, brain fog, and chronic illness — plus clinical testing and protocols to restore cellular energy production.
A physician's review of molecular hydrogen water — mechanisms, clinical trial data, dosing, and how it fits a longevity protocol. Evidence-based, hype-free.
Mitophagy removes damaged mitochondria to protect energy, cognition, and lifespan. A physician explains what activates it, what blocks it, and how to optimize it.
Pyrroloquinoline quinone (PQQ) promotes mitochondrial biogenesis, neuroprotection, and cellular energy. Dr. Douwes reviews the evidence and clinical dosing protocols.
How aligning your biological clock with light, food, and movement extends healthspan — evidence-based strategies from a longevity physician's clinical practice.
A physician's guide to sirtuins—the NAD+-dependent enzymes that regulate aging, metabolism, DNA repair, and inflammation across every organ system.
Apigenin inhibits CD38 to raise NAD+ levels, clears senescent cells, and deepens sleep. A physician's evidence-based guide to dosing, stacking, and safety.
Clinical review of NMN supplementation: mechanisms, human trial data, optimal dosing (250–1,000 mg/day), forms ranked by bioavailability, and candidacy criteria.
Sulforaphane activates the NRF2 pathway to upregulate cellular defenses. A physician's review of clinical evidence, bioavailability, and dosing strategies.
Dr. Julian Douwes reviews the evidence on alpha-ketoglutarate (AKG) supplementation — from TCA cycle biochemistry to epigenetic aging and clinical dosing.
A physician's review of resveratrol's SIRT1 activation, cardiovascular and neuroprotective data, bioavailability limits, and practical dosing for longevity.
A physician's comparison of every oral NAD+ precursor — NMN, NR, NADH, and NAD3 — covering mechanisms, dosing, cofactors, and when to upgrade to IV therapy.
A physician's guide to NAD+ IV therapy side effects: what causes them, which are common vs serious, how to minimize discomfort, and who should avoid treatment.
A practicing physician's evidence-based anti-aging supplement stack. NAD+, resveratrol, CoQ10, omega-3, vitamin D — what works, what's overhyped, and what I actually take.
NAD+ IV injections vs oral NMN vs sublingual NAD+ compared. Bioavailability data, clinical outcomes, cost analysis, and what I recommend in practice.
NAD+ IV, NMN, and NR compared by a physician. Bioavailability, evidence, cost, and who benefits from which approach based on clinical experience.
Epithalon vs NMN comparison by Dr. Julian Douwes. Telomere lengthening vs NAD+ replenishment — different aging hallmarks, different evidence, and when to use each.
How NAD+ IV therapy supports mitochondrial function and cellular repair. Evidence, clinical experience, and what patients should know.